Lymphoma, Extranodal NK-T-Cell
"Lymphoma, Extranodal NK-T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An extranodal neoplasm, usually possessing an NK-cell phenotype and associated with EPSTEIN-BARR VIRUS. These lymphomas exhibit a broad morphologic spectrum, frequent necrosis, angioinvasion, and most commonly present in the midfacial region, but also in other extranodal sites.
| Descriptor ID |
D054391
|
| MeSH Number(s) |
C04.557.386.480.750.199
|
| Concept/Terms |
Lymphoma, Extranodal NK-T-Cell- Lymphoma, Extranodal NK-T-Cell
- Extranodal NK-T-Cell Lymphomas
- Lymphoma, Extranodal NK T Cell
- Lymphomas, Extranodal NK-T-Cell
- NK-T-Cell Lymphoma, Extranodal
- NK-T-Cell Lymphomas, Extranodal
- Extranodal NK-T-Cell Lymphoma
- Extranodal NK T Cell Lymphoma
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type- Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
- Extranodal NK T Cell Lymphoma, Nasal and Nasal Type
- Extranodal NK-T-Cell Lymphoma, Nasal Type
- Extranodal NK T Cell Lymphoma, Nasal Type
- Extranodal NK-T-Cell Lymphoma, Nasal
- Extranodal NK T Cell Lymphoma, Nasal
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Extranodal NK-T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Extranodal NK-T-Cell".
This graph shows the total number of publications written about "Lymphoma, Extranodal NK-T-Cell" by people in this website by year, and whether "Lymphoma, Extranodal NK-T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2021 | 5 | 0 | 5 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, Extranodal NK-T-Cell" by people in Profiles.
-
Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study. Clin Lymphoma Myeloma Leuk. 2024 Nov; 24(11):e808-e818.
-
Encouraging prospects with sugemalimab in relapsed or refractory extranodal natural killer/T-cell lymphoma. Chin Clin Oncol. 2024 Feb; 13(1):17.
-
Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters-Reply. JAMA Oncol. 2023 02 01; 9(2):279-280.
-
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS. Haematologica. 2022 08 01; 107(8):1864-1879.
-
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial. JAMA Oncol. 2022 07 01; 8(7):1035-1041.
-
Chemoradiation to Improve Local Control, and Thereby Overall Survival for Limited Stage Nasal NKTCL. Int J Radiat Oncol Biol Phys. 2021 Dec 01; 111(5):1105-1106.
-
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma. Blood. 2021 08 12; 138(6):452-463.
-
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study. Ann Hematol. 2021 Oct; 100(10):2529-2539.
-
CD94 expression patterns in reactive and neoplastic T-cell and NK-cell proliferations. Leuk Res. 2021 09; 108:106614.
-
Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2021 Jul 15; 110(4):1064-1081.